MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Assessment of cognitive impairment in Parkinson’s disease in under-represented ethnic groups-The London-Dhaka Parkinson’s Cognitive Study

    T. Zannat, KC. Dey, A. Zirra, A. Haque, E. Camboe, D. Mair, T. Haque, S. Waters, CR. Marshall, RS. Weil, S. Ali, N. Mukadam, AJ. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: The aim of this study is to evaluate the prevalence of CI in a diverse group of PwP from East London, UK and Dhaka,…
  • 2024 International Congress

    To develop and study the efficacy of Telephonic Psychotherapy on the Global Neuropsychological functioning of PD Patients: An RCT

    R. Hazrati, R. Makkar, A. Nehra (New Delhi, India)

    Objective: A single blinded RCT was conducted to develop and test the efficacy of a telephonic psychotherapy on PD Patients. PD patients bound by movement…
  • 2024 International Congress

    Blood Pressure Profile of PD-MCI and PDD in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    A. Al Jody, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)

    Objective: This study aims to explore the BP profile in both PD-MCI and PDD Background: Blood pressure (BP) abnormality is often correlated with cognitive impairment. However,…
  • 2024 International Congress

    Comparative Effectiveness of Behavioral or Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease

    C. Vaughan, J. Morley, J. Lehosit, G. Mcgwin, L. Muirhead, A. Khakharia, T. Johnson Ii, M. Evatt, T. Sergent, K. Burgio, A. Markland (Atlanta, USA)

    Objective: Assess the comparative effectiveness of behavioral or solifenacin drug therapy over 12 weeks for overactive bladder (OAB) symptoms according to the International Consultation on…
  • 2024 International Congress

    SCN9A Gene Variant in a PD Case with Refractory Dysesthesias

    J. Park, B. Barton (Chicago, USA)

    Objective: Describe an unusual case of severe pain syndrome associated with a predisposing genetic mutation, and review literature on causes of enhanced pain in PD.…
  • 2024 International Congress

    Age of Onset and Non-Motor Symptoms in Early Parkinson’s Disease: A Data-Analysis Study Based on the Fox Insight Cohort

    A. Oliveira Franco, D. Teixeira-Dos-Santos, A. Noyce, S. Bandres-Ciga, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To compare late-onset and early-onset patients with Parkinson’s Disease (PD) in how they differ from their matched healthy controls (HC) regarding the presence of…
  • 2024 International Congress

    Nocturnal Bradykinesia is better detected using wearable sensors in Parkinson’s disease compared to clinical outcome

    I. Murasan, M. Qamar, K. Poplawska-Domaszewicz, D. Trivedi, K R. Chaudhuri, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To evaluate the range and motor state during sleep of PD patients by using subjective scale-based assessment as well as PKG.  To evaluate the…
  • 2024 International Congress

    Association Between Hypertension Timing and Clinical Variables in Parkinson’s Disease: A Retrospective Analysis

    WF. Moguel Cardín, AL. Guerra Anzaldo, GA. Espinosa Cruz, A. Adam Castro, A. Dominguez García, A. Cervantes Arriaga, M. Rodríguez Violante, AJ. Hernández Medrano, G. Rivera Monroy, K. Velázquez Román, RJ. Baños Betancourt, CF. álvarez Hernández, DP. Romero Terán, JC. Delgado Uriarte, NP. Moreno Aldama, MC. Unda Mcfarlane, A. Uribe León (Ciudad de Mexico, Mexico)

    Objective: To investigate the correlation between hypertension and Parkinson's disease (PD) diagnoses' timing and clinical variables. Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder…
  • 2024 International Congress

    Psychotic features in patients with Parkinson’s disease

    S. Frikha, O. Ben Othmen, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: The objective of the study was to assess the psychotic symptoms associated with Parkinson's disease (PD) and to establish statistical correlations with sociodemographic and…
  • 2024 International Congress

    12 year gap analysis in Parkinson’s Disease mortality in Brazil

    L. Lobato, M F. Felippe, M. Fin, V. Souza, I. Fink, V. Muller, C. Rieder (Porto Alegre, Brazil)

    Objective: Examine patterns in Parkinson’s Disease (PD) mortality by sex and age groups over 50 years old in Brazil, using official data from a 12…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley